A new paediatric formulation of valaciclovir : development and bioequivalence assessment
Citation
Bastiaans , D E T , Bartels-Wilmer , C M , Colbers , A P H , Heijens , C A W , Velthoven-Graafland , K , Smeets , O S N M , Vink , N , Harbers , V E M , Warris , A & Burger , D M 2016 , ' A new paediatric formulation of valaciclovir : development and bioequivalence assessment ' , Archives of Disease in Childhood , vol. 101 , no. 10 , pp. 971-972 . https://doi.org/10.1136/archdischild-2015-310266
Rights
This article has been accepted for publication in Archives of Disease in Childhood following peer review. The definitive copyedited, typeset version Bastiaans, DET, Bartels-Wilmer, CM, Colbers, APH, Heijens, CAW, Velthoven-Graafland, K, Smeets, OSNM, Vink, N, Harbers, VEM, Warris, A & Burger, DM 2016, 'A new paediatric formulation of valaciclovir: development and bioequivalence assessment' Archives of Disease in Childhood, vol 101, no. 10, pp. 971-972., 10.1136/archdischild-2015-310266 is available online at: http://adc.bmj.com/content/101/10/971